Summary.-Ploidy and cell-cycle stage were determined by flow cytometry (FCM) 
FLOW CYTOMETRY (FCM) has been applied in a variety of studies (Barlogie et al., 1978 (Barlogie et al., , 1980 Bichel et al., 1977; M0rk & Laerum, 1980; Tribukait & Eposti, 1976) in order to characterize various human tumours in terms of DNA content. In some studies, few tumours with abnormal DNA content (aneuploid*) were found, whereas Barlogie et al. (1978 Barlogie et al. ( , 1980 ) determined more than 90% with aneuploid abnormalities. This discrepancy is partly due to the experimental technique and partly to the definition of "abnormal ploidy". For the clinic, the correlation of a measured parameter with prognosis is of special interest. There have been several attempts to assess an interrelationship between histological findings, ploidy, proliferative activity and prognosis (Van der Werf-Messing, 1978; Atkin & Kay, 1979; M0rk & Laerum, 1980; Scarffe et al., 1980) . However, the results diverge, and they depend especially on the type of cancer and other unknown parameters. Obviously, more data are needed to arrive at more reliable conclusions.
In the present study, the DNA content as well as the fractions of cells in the various phases of the cycle were determined for 46 human kidney carcinomas by flow cytometry. For 3 samples, the labelling index was measured by autoradiography (ARG). Most of the tumours were examined histologically, using the grading systems described by Syrjanen & Hjelt (1978) . These authors have shown a correlation between the histological grad-ing and prognosis for renal carcinomas. The aim of our study was to determine the frequency of aneuploid cell lines in human kidney carcinomas and to find an interrelationship between the FCM data (i.e. ploidy level and proliferative state), the histological grading and prognosis. At present, only preliminary results, especially in respect of prognosis, can be presented, as the study was initiated only 2 years ago.
MATERIALS AND METHODS

Tumours and irradiation
Forty-six human renal adenocarcinomas were studied, grouped into 3 treatment protocols: (a) 19 tumours were removed by nephrectomy without pre-irradiation. (b) 13 tumours were pre-irradiated with a total dose of 25 Gy of 42 MeV X-rays, given within 2 2 weeks, and removed 6 weeks after the beginning of radiotherapy. (c) 14 tumours were pre-irradiated with 60Co y-rays at a total dose of 15 Gy in 5 Gy fractions on 3 successive days, and removed the day after the last irradiation. From each surgical specimen, 3 samples were taken for flowr cytometry and, in some cases, for ARG: one from the kidney tissue, one from the tumour periphery and one from the tumour centre.
Flow cytometry and autoradiography
Preparations and staining of tumour specimens for FCM was performed as described previously (Roters et al., 1978) . The DNA of the cells was stained with a mixture of ethidium bromide (5 ,tg/ml) and mithramycin (12.5 ,ug/ml) in Tris buffer.DNA distributions were recorded on a flow cytometer ICP 22 (Phywe, G6ttingen, FRG) on line with a Wang computer 2200B (Wang, Tewksbury. U.S.A.). The fractions of cells in the various phases of the cell cycle were determined as described by Beck (1980) . The absolute DNA content of the tumour cells was determined by calibrating the instrument with kidney cells, which are known to have the normal diploid DNA content (2c) of 6 pg/cell. 3H-labelling indices were determined from tissue samples which had been incubated in vitro for 1 h at 37°C under high 02 pressure with 10 ,tCi/ml 3H-thymidine. ARGs of Feulgen-stained 3 jim slices were prepared using Ilford K2 emulsion and the goldactivation technique (Braunschweiger et al. (1976) .
Histology
Histological grading was performed according to the two systems introduced by Syrjanen & Hjelt (1978 Figure 1 shows FCM DNA histograms of normal kidney tissue and 2 renal adenocarcinomas. The kidney cells (A) were used as a standard for determining the DNA content of the tumour cell lines. B shows a purely diploid tumour, whereas the tumour of C contains a diploid (2c DNA content) as well as a hyperdiploid (3 5c) cell population. Fig. 2 shows a tumour with pronounced differences between the periphery and the centre, and demonstrates the evaluation procedure for the FCM histograms. The raw data of the kidney tissue (A) and the tumour periphery (B) look rather similar because of the semi-logarithmic plot, but after background subtraction and correction for clumped cells the (G2 + M) peak of the tumour appears considerably higher than that of the normal kidney tissue. In this particular tumour a hyperdiploid cell population, in addition to the diploid one, was found in the sample from the centre (C). Since the renal carcinomas are usually large, the collected samples represent only a very small part of the tumour. If a small hyperdiploid population were confined to a distinct region, it could easily be missed by taking only 2 samples. However, for 18/21 tumours the aneuploid population was found both in the centre and at the periphery. In 3 cases, the hyperdiploid population appeared only in one of the 2 samples. This shows that the probability of missing the hyperdiploid population in both tumour samples is less than 1 0.
Hyperdiploid cell populations were found in 21 tumotirs (i.e. 46%) of a total of 46. The results are compiled in Table 1 . For all diploid tumour-cell populations investigated, including those of Table I (population 1) an average of 5 9 + 0 5 (s.e.) pg DNA per G1 cell was obtained. This agrees well with the known value of 6 pg for human diploid cells. Therefore the ploidy of population 2 was calculated on the assumption that the accompanying population I had 2 complements of DNA. For all tumours with one cell population, the deviation from the mean was within statistical limits (according to a Dixon test at the 5%0 level) except for sample 1O in Table I . Therefore this tumour with 7-9 pg DNA content was assigned to be hyperdiploid and included in the table, despite having only 1 population. In I case (7) we measured a hypoploid population (1 5c) in addition to the diploid and the hyperdiploid ones. The percentages of cells in the 2 populations, listed in the last columns, differ considerably from sample to sample. (Table I ). In principle, the diploid population in the FCM histograms might also include normal kidney cells and macrophages. Histological inspection, however, showed that the great majority of cells were tumour cells in all samples investigated. The tumours were classified as aneuploid only when a second peak in addition to the diploid one appeared in the FCM histogram or, as in one exception, when the difference from the DNA content of normal tissue was highly significant. However, a small hypodiploid or hyperdiploid population with DNA content near 2c cannot be separated from a greater 2c peak in the histogram. Considering the coefficients of variation of 4-9% in the histograms, we estimated that a near-diploid peak could only be identified if it had a DNA content at least 20% lower or higher than the corresponding 2c peak. That means that our "hyperdiploid" group contains only tumours with cell lines of DNA content 2-4c or more (cf. Table I , column 5). In some tumours, the cell population 2 with the higher DNA content has a ploidy close to 4c; i.e. the peak appears at nearly the same position as the (G2 + M) peak of population 1 with diploid DNA content. These samples were classified as hyperdiploid only if S-phase cells did not appear between the 2c and 4c peaks, and if, in addition, a peak at 8c (G2 + M) cells of population 2 appeared, which was smaller than the 6c peak, so that it could not be caused by clumping of diploid cells.
The DNA content of a variety of human tumours, including 9 renal carcinomas, was measured by Atkin & Kay (1979 (Baisch et al., 1982) , which are mainly because background subtraction has to be performed in evaluating FCM data of tumour samples (Beck, 1980) . In contrast to FCM, even a few cells in S phase can be clearly identified by ARG. The good agreement between our ARG and FCM results (Table III) shows that the low fractions of cells in 5, obtained by FCM, are quite reliable. Our ARG results agree also with the findings of Rabes (1980) , who reported labelling indices for renal carcinomas of 1-5*8%. For the hyperdiploid populations we measured higher fractions in S + (G2 + M) than in diploid populations (Table II) . This finding is also supported by our observation that the tumours containing hyperdiploid lines show more mitoses than the diploid ones, and are hence more frequently classified as Grade III or IV by histology (see Table IV ).
The pre-irradiated tumours showed little change in size of S and (G2 + M) fractions from the unirradiated ones (Table II) . From a cell-kinetic point of view one should expect that irradiation with 15 Gy the day before removal of the tumour should cause a measurable G2 block, whereas 25 Gy 6 weeks before nephrectomy and FCM measurement should give the tumours time to recover and attain a balanced growth. But the results for the different treatment protocols were similar. The reason may be that any differences, if they exist, would be too small to be detected by FCM, since the proportion of hyperdiploid cells varies greatly from tumour to tumour, and the fraction of non-proliferating cells (as indicated by the large proportion in Go + G1) is high.
Aneuploidy measured by FCM correlates with histological grading: 55% of the hyperdiploid tumours are of nuclear Grade III and IV, compared with only 11% of the diploid tumours (Table IV) . On the other hand, all tumours of Grade IV and 67% of Grade III were hyperdiploid. The hyperdiploid DNA content obviously does not always lead to morphological changes in the cell nucleus, but the increase in DNA content may be a prior event which eventually causes morphological changes. Some of the diploid tumours are also of high nuclear grade. Aneuploidy thus seems to be a possible but not necessary result ofmalignant transformation. For the characterization of a tumour, the ploidy level may be a useful additional parameter to the histological grading. The demarcation and infiltration (denoted A and B in the combined histological grading system) does not correlate to the ploidy for the lower Grades I and II, but all Grade III tumours were poorly demarcated (B). Except for the most mialignant tumours, infiltration seems to be a characteristic uncorrelated to cell features.
The aneuploidy measured by FCM is shown to be relevant for prognosis.
Nearly 50% of the patients with hyperdiploid tumours had a bad prognosis, whereas only I out of 11 patients with diploid tumours have died up to now. However, the period of follow-up was only 6 months to 2 years; i.e., only the early multiple metastases and deaths were observed. The number of tumours in Table VI is less than the total number in the study, because in some cases the fate of the patients was uncertain. A slight correlation between aneuploidy and poor prognosis was also found by Atkin & Kay (1979) for various types of ttumours. Our present data indicate that this tendency is more pronounced for renal carcinomas. We also found a good correlation between histological grading and prognosis (Table VI) . This generally agrees with the follow-up study based on histological grading by Syrjanen & Hjelt (1978) . They showed that patients with renal carcinomas of higher grades had considerably lower 5-year survivals than the low-grade groups.
In our study, all Grade IV tumours were hyperdiploid and had a bad progniosis (Table IV) . On the other hand, the tumours of the lower grades were not always diploid. Even in the lowest Grade I group, 2/10 tumours were hyperdiploid. Obviouisly the ploidy characteristic is not strictly correlated with nuclear morphology. Interestingly, in the group of patients who died during the period of observation, both Grade II tumours and 1/2 Grade III tumours were hyperdiploid. The 2 patients with Grade II tumours died about 2 years after nephrectomy. For the remaining low-grade, hyperdiploid tumours the follow-up period has probably been too short. But the present results already indicate that ploidy can be used as an independent parameter with respect to prognosis. It is hoped that a grading sy-stem based on both FCAI ploidy and histological grades might improve the prognostic possibilities for this particular human tumour.
